Selim M. Arcasoy, M.D., M.P.H.

Dickinson W. Richards, Jr. Professor of Medicine (in Pediatrics)
Medical Program Director, Lung Transplantation Program


Dr. Arcasoy was recruited to Columbia University/NewYork-Presbyterian Hospital as the Medical Program Director of Lung Transplantation in 2001 from the University of Pennsylvania, where he was a key member of the Advanced Lung Disease and Lung Transplantation Program in the Division of Pulmonary and Critical Care Medicine. After his recruitment, he completely turned around the Lung Transplantation Program to rank amongst the top 5 to 10 programs in the country with regards to volume and top 1 to 5 programs in terms of patient survival. Under his leadership, the Lung Transplant Program has performed 60-70 transplants annually in the past 6 years with a record number of 71 transplants in 2017. Despite high transplant volumes and very sick pretransplant candidates, the survival of lung transplant recipients has remained significantly above the national average. Currently, 1-year survival of lung transplant recipients at Columbia University is 90%, 5-year survival 68%, and 10-year survival 46% (as compared to 85%, 55%, and 28% national average survival at the same time points).

Dr. Arcasoy has gained national and international reputation with various leadership roles in many professional organizations and scientific societies. He previously chaired the Thoracic Organ Transplant Committee of the American Society of Transplantation and the Transplant Network Steering Committee of the American College of Chest Physicians. Dr. Arcasoy is a Fellow of the American College of Physicians (FACP), American College of Chest Physicians (FCCP), and American Society of Transplantation (FAST). He serves as a reviewer for many scientific journals. Dr. Arcasoy has been named in America's Top Doctors and Top Doctors: New York Metro area in the past 16 consecutive years. He has also been selected in the New York Times Super Doctors list in the past 10 years.

Dr. Arcasoy's main research interests include outcomes of patients with advanced lung disease before and after lung transplantation, post-transplant complications, optimization of post-transplant immunosuppression via multicenter clinical trials and collaborative investigation in immune tolerance, studies of genetic testing for diagnosis of organ rejection, various post-transplant complications and lung allocation policy. His research has been published in journals such as the New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine, Annals of Internal Medicine, Chest, American Journal of Transplantation, Journal of Heart and Lung Transplantation, Gene Therapy, and Transplantation. Between 2011 and 2013, Dr. Arcasoy attended the Executive Program and obtained his Master of Public Health degree in Healthcare Policy and Management from Columbia University Mailman School of Public Health. He maintains a very busy clinical practice in addition to administration of the Lung Transplant Program, teaching and clinical research. He is also heavily engaged in philanthropy and works arm in arm with some of his grateful patients to raise funds to meet the needs of his Program and patients focusing on cutting-edge research, education and building a strong patient community.

Education and Training

Tarsus American College, Tarsus, Turkey, 1977-1984
Medical School:
Ege University Medical School, Turkey, 1984-1990
State University of New York (SUNY) Health Science Center at Brooklyn, NY, 1990-1993
Chief Residency:
SUNY Health Science Center at Brooklyn, NY, 1993-1994
Pulmonary and Critical Care Medicine, University of Pittsburgh, PA, 1994-1997
Research Fellowship:
Pulmonary and Critical Care Medicine, University of Pittsburgh, PA, 1997-1998
Master of Public Health:
Executive Master of Public Health in Healthcare Policy Management
Columbia University Mailman School of Public Health, NY, 2011-13

Selected Honors and Awards

Fellow of the American Society of Transplantation (F.A.S.T.)
Inclusion in America’s Top Doctors and Top Doctors: New York Metro Area
Inclusion in New York City Super Doctors, New York Times Magazine
Fellow of the American College of Physicians (F.A.C.P.)
Fellow of the American College of Chest Physicians (F.C.C.P.)
Rank Valedictorian of class in Ege University School of Medicine
Rank Valedictorian of class in Tarsus American College


For appointments: 

Lung Transplant Program
622 W. 168th Street, PH-14
New York, NY 10032-3784

P: (212) 305-7771


  • Lung Transplant
  • Pulmonary Disease Medicine

Clinical Expertise

  • Lung Transplantation
  • Advanced Lung Disease
  • Interstitial Lung Disease
  • Pulmonary Thromboembolism
  • Rare Lung Diseases

Clinical Centers

Board Certifications

  • Re-certification in Internal Medicine, 2013
  • Re-certification in Pulmonary Medicine, 2016
  • Re-certification in Critical Care Medicine, 2016

In the News

Dr. Selim Arcasoy, medical director of our Lung Transplant Program, recently visited The Path Forward with Cystic Fibrosis podcast and its host, Jerry Cahill, to discuss lung transplants, the pre-transplant process and what happens once someone is on the lung transplant list.

Watch the video to hear Dr. Arcasoy answer questions like:

  • When should a CF patient consider a lung transplant?
  • What is the transplant listing process?
  • What is the transplant evaluation process?
  • What are some testing and evaluation obstacles, both mental and psychosocial?
  • What is dual listing?
  • What happens when you are actively listed?


Research Interests

  • Outcomes of patients with advanced lung disease before and after lung transplantation
  • Post-transplant complications
  • Optimization of Post-transplant immunosuppression via clinical trials

Selected Publications

  1. S.M. Arcasoy, R.M. Kotloff. Lung transplantation. N Engl J Med 1999;340:1081-91.
  2. S.M. Arcasoy, C. Hersh, J.D. Christie, D. Zisman, A. Pochettino, B.R. Rosengard, N.P. Blumenthal, H.I. Palevsky, J.E. Bavaria, R.M. Kotloff. Bronchogenic carcinoma Complicating Lung Transplantation. J Heart Lung Transplant 2001;20:1044-53.
  3. S.M. Arcasoy, J.D. Christie, V.A. Ferrari, M. St. John Sutton, D.A. Zisman, N.P. Blumenthal, A. Pochettino, R.M. Kotloff. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40.
  4. S.M. Arcasoy, A. Fisher, R.R. Hachem, M. Scavuzzo, L.B. Ware. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction. Part V: Predictors and Outcomes. J Heart Lung Transplant 2005;24:1483-8.
  5. J.B. Orens, M. Estenne, S. Arcasoy, J.V. Conte, P. Corris, J.J. Egan, T. Egan, S. Keshvajee, C. Knoop, R. Kotloff, F.J. Martinez, S. Nathan, S. Palmer, A. Patterson, L. Singer, G. Snell, S. Studer, J.L. Vachiery, A.R. Glanville. International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update. J Heart Lung Transplant 2006;25:745-55.
  6. M.R. Celik, D.J. Lederer, J. Wilt, D. Eser, M. Bacchetta, F. D'Ovidio, J.R. Sonett, S.M. Arcasoy. Tacrolimus and Azathioprine versus Cyclosporine and Mycophenolate Mofetil after Lung Transplantation: A Retrospective Cohort Study. J Heart Lung Transplant 2009;28:697-703.
  7. S.M. Arcasoy, G. Berry, C.C. Marboe, H.D. Tazelaar, M.R. Zamora, H.J. Wolters, K.C. Fang, S. Keshavjee for the LARGO Study Investigators. Pathologic Interpretation of Transbronchial Biopsy For Acute Rejection of Lung Allograft Is Highly Variable. Am J Transplant 2011;11:320-8.
  8. A.M. Layton, H.F. Armstrong, H.P. Kim, K.S. Meza, F. D’Ovidio, S.M. Arcasoy. Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation. Respir Med 2017; 126: 59-67
  9. L.J. Benvenuto, D.R. Anderson, H.P. Kim, J.L. Hook, L. Shah, H.Y. Robbins, F. D’Ovidio, M. Bacchetta, J.R. Sonett, S.M. Arcasoy. Geographic disparities in donor lung supply and lung transplant waitlist outcomes: A Cohort Study. Am J Transplant; 2018; 18:1471-80
  10. L.J. Benvenuto, M.R. Anderson, S.M. Arcasoy. New frontiers in immunosuppression. J Thorac Dis 2018;10(5):3141-55.

View Dr. Arcasoy's full list of publications from PubMed